Prognostic Biomarkers for Acute Graft-versus-Host Disease Risk after Cyclophosphamide–Fludarabine Nonmyeloablative Allotransplantation

作者: Robert P Nelson Jr , Muhammad Rizwan Khawaja , Susan M Perkins , Lindsey Elmore , Christen L Mumaw

DOI: 10.1016/J.BBMT.2014.06.039

关键词:

摘要: Abstract Five candidate plasma biomarkers (suppression of tumorogenesis 2 [ST2], regenerating islet-derived-3α [REG3α], elafin, tumor necrosis factor receptor 1 [TNFR1], and soluble IL-2 receptor-alpha [sIL2Rα]) were measured at specific time points after cyclophosphamide/fludarabine-based nonmyeloablative allotransplantation (NMAT) in patients who did or not develop acute graft-versus-host disease (aGVHD). Plasma samples from 34 analyzed days +7, +14, +21, and +30. At a median follow-up 358 days, 17 had experienced aGVHD with to onset day +36. Risk was associated elevated ST2 concentrations day +7 (c-statistic = .72, P = .03), day +14 (c-statistic = .74, P = .02), day +21 (c-statistic = .75, P = .02); REG3α (c-statistic = .73, (c-statistic = .76, P = .01), day +30 P = .03); elafin (c-statistic = .71, P = .04). TNFR1 sIL2Rα associated risk any the studied. This study identified ST2, REG3α, as prognostic evaluate NMAT. These results need be confirmed an independent validation cohort.

参考文章(13)
Przepiorka D, Weisdorf D, Hows J, Beatty P, Martin P, Klingemann Hg, Thomas Ed, 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation. ,vol. 15, pp. 825- 828 ,(1995)
A.J. Barrett, R. Childs, E. Clave, N. Contentin, D. Jayasekera, N. Hensel, S. Leitman, E.J. Read, C. Carter, E. Bahceci, N.S. Young, Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood. ,vol. 94, pp. 3234- 3241 ,(1999) , 10.1182/BLOOD.V94.9.3234
James L. M. Ferrara, Andrew C. Harris, Joel K. Greenson, Thomas M. Braun, Ernst Holler, Takanori Teshima, John E. Levine, Sung W. J. Choi, Elisabeth Huber, Karin Landfried, Koichi Akashi, Mark Vander Lugt, Pavan Reddy, Alice Chin, Qing Zhang, Samir Hanash, Sophie Paczesny, Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease Blood. ,vol. 118, pp. 6702- 6708 ,(2011) , 10.1182/BLOOD-2011-08-375006
John E. Levine, Brent R. Logan, Juan Wu, Amin M. Alousi, Javier Bolaños-Meade, James L. M. Ferrara, Vincent T. Ho, Daniel J. Weisdorf, Sophie Paczesny, Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study Blood. ,vol. 119, pp. 3854- 3860 ,(2012) , 10.1182/BLOOD-2012-01-403063
Hiroko Hayakawa, Morisada Hayakawa, Akihiro Kume, Shin-ichi Tominaga, Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation Journal of Biological Chemistry. ,vol. 282, pp. 26369- 26380 ,(2007) , 10.1074/JBC.M704916200
Mark T. Vander Lugt, Thomas M. Braun, Samir Hanash, Jerome Ritz, Vincent T. Ho, Joseph H. Antin, Qing Zhang, Chee-Hong Wong, Hong Wang, Alice Chin, Aurélie Gomez, Andrew C. Harris, John E. Levine, Sung W. Choi, Daniel Couriel, Pavan Reddy, James L.M. Ferrara, Sophie Paczesny, ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death The New England Journal of Medicine. ,vol. 369, pp. 529- 539 ,(2013) , 10.1056/NEJMOA1213299
R P Nelson, M Yu, J E Schwartz, M J Robertson, R Hromas, C A Fausel, G H Vance, S R Dlouhy, J A Baute, E A Cox, L L Wood, S Srivastava, K A Robertson, P R Haut, S S Farag, R Abonour, K Cornetta, L D Cripe, Long-term disease-free survival after nonmyeloablative cyclophosphamide/ fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia Bone Marrow Transplantation. ,vol. 45, pp. 1300- 1308 ,(2010) , 10.1038/BMT.2009.348
Sophie Paczesny, Thomas M Braun, John E Levine, Jason Hogan, Jeffrey Crawford, Bryan Coffing, Stephen Olsen, Sung W Choi, Hong Wang, Vitor Faca, Sharon Pitteri, Qing Zhang, Alice Chin, Carrie Kitko, Shin Mineishi, Gregory Yanik, Edward Peres, David Hanauer, Ying Wang, Pavan Reddy, Samir Hanash, James LM Ferrara, Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin Science Translational Medicine. ,vol. 2, ,(2010) , 10.1126/SCITRANSLMED.3000406
Robert Chen, Joycelynne M. Palmer, Ni-Chun Tsai, Sandra H. Thomas, Tanya Siddiqi, Leslie Popplewell, Len Farol, Auayporn Nademanee, Stephen J. Forman, Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma Biology of Blood and Marrow Transplantation. ,vol. 20, pp. 1864- 1868 ,(2014) , 10.1016/J.BBMT.2014.06.037